Allied Market Research

2024

Swine Health Market

Swine Health Market Size, Share, Competitive Landscape and Trend Analysis Report by Disease (Aujeszky's Disease (AD), Classical Swine Fever (CSF), Actinobacillus Pleuropneumonia, Mycoplasma Hyopneumoniae, Swine Enteric Coronavirus Disease, Porcine Reproductive and Respiratory Syndrome (PRRS), Salmonella) and by Route of Administration (Injectable, Oral): Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Swine health is associated with the diseases caused due to pigs and the development of therapeutics to prevent the related ailments and disorders. Pig breeding can lead to many diseases such as reproductive disease and congenital malformations. Hence, governmental organizations are launching programs to protect and enhance the health of swine, which reduces the effect of swine diseases on humans.

Increase in incidences of diseases through swine drive the market. However, high cost associated with swine health especially in the developing countries impede the market growth. Moreover, key market players investing in R&D activities to develop novel therapeutics to address unmet medical needs create lucrative opportunities.

Swine health market is segmented based on diseases, route of administration, and geography. Based on diseases, the market is divided into aujeszkys disease (AD), classical swine fever (CSF), actinobacillus pleuropneumonia, mycoplasma hyopneumoniae, swine enteric coronavirus disease, porcine reproductive and respiratory syndrome (PRRS), and salmonella. Based on route of administration, the market is classified into injectable and oral. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Neogen Co, Norbrook Group, Orion Pharma, Phibro Animal Health, Vetoquinol Animal Health Pvt Ltd, Bio-Vet, Dechra Pharmaceuticals PLC, ECO Animal Health, Huvepharma SEA Private Limited, and Indian Immunologicals are provided in this report.

Key Benefits

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global swine health market.
  • In-depth analysis is conducted by constructing market estimations for key market segments.
  • This study that evaluates the competitive landscape and value chain is taken into account to help understand the competitive environment globally.
  • Comprehensive analysis of factors that drive and restrict the growth of the global swine health market is provided.
  • This report provides the quantitative analysis of the current market and estimations which assists in identifying prevailing market opportunities
  • Comprehensive analysis of all regions is provided that determines prevailing opportunities in these regions.

Swine Health Market Report Highlights

Aspects Details
Swine Health Market By Disease
By Disease
  • Aujeszky's Disease (AD)
  • Classical Swine Fever (CSF)
  • Actinobacillus Pleuropneumonia
  • Mycoplasma Hyopneumoniae
  • Swine Enteric Coronavirus Disease
  • Porcine Reproductive and Respiratory Syndrome (PRRS)
  • Salmonella
Swine Health Market By Route of Administration
By Route of Administration
  • Injectable
  • Oral
Swine Health Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Turkey, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players
Key Market Players

Huvepharma SEA Private Limited, Neogen Co, Indian Immunologicals, Vetoquinol Animal Health Pvt Ltd, Orion Pharma, ECO Animal Health, Bio-Vet, Phibro Animal Health, Norbrook Group, Dechra Pharmaceuticals PLC

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Swine Health Market

Global Opportunity Analysis and Industry Forecast, 2023-2032